Coenzyme q10 with hmg-coa reductase inhibitors
CA 2007983 C · Owner: Tobert, Jonathan A. · Inventors: Brown, Michael S.; Tobert, Jonathan A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition and method of counteracting HMG-CoA reductase inhibitor-associated myopathy is disclosed. The method comprises the adjunct administration of an effective amount of a HMG-CoA reductase inhibitor and an effective amount of Coenzyme Q10. Also disclosed is a method for, counteracting HMG-COA reductase inhibitor-associated elevated transaminase levels, which comprises the adjunct administration of an effective amount of a HMG-COA reductase inhibitor and an effective amount of coenzyme Q10.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 1990 and granted December 10, 1996. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 17, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.